Summary
For Year 2026-27, Nidan Laboratories And Healthcare reports the following shareholding: Total Promoters at 57.04%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 42.96%. This breakdown provides a quick snapshot of ownership distribution for Nidan Laboratories And Healthcare in 2026-27.
Nidan Laboratories And Healthcare FAQs
As of 04-2026, the promoter shareholding in Nidan Laboratories And Healthcare stands at 57.04% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Nidan Laboratories And Healthcare is 0% and 0% respectively.
The retail shareholding of the Nidan Laboratories And Healthcare is 42.96%.
Changes in shareholding patterns of Nidan Laboratories And Healthcare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Nidan Laboratories And Healthcare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Nidan Laboratories And Healthcare Associated Pages
- Nidan Laboratories And Healthcare Share Price
- Nidan Laboratories And Healthcare Share Price chart
- Nidan Laboratories And Healthcare Fundamental Analysis
- Nidan Laboratories And Healthcare Technical Analysis
- Nidan Laboratories And Healthcare Peer Comparison
- Nidan Laboratories And Healthcare Share Price History
- Nidan Laboratories And Healthcare Board of Directors
